NIH ordered to eliminate $2.B in federal contracts

April 8 is the deadline for a 35% cut in services that could affect specimen storage, genetic counseling, and administration.

April 3, 2025 Check out STAT+

Sponsored By

Want to learn more about the future of brain health? Join STAT this Sunday in San Diego at an event that will bring together reporters, industry experts, and thought leaders to dive into the latest trends in neurology and what's on the horizon for this year's American Academy of Neurology Annual Meeting. Register now.

Adobe STAT+ | Trump administration orders NIH to eliminate $2.6 billion in federal contracts The NIH is given a deadline of April 8 to make a 35% cut in services that may include specimen storage, genetic counseling, and administration. By Megan Molteni STAT+ | DOJ urges judge to move forward with Medicare Advantage fraud case against UnitedHealth The government alleges UnitedHealth failed to return at least $2 billion in Medicare Advantage overpayments in a case dating back years. By Tara Bannow and Bob Herman HHS cuts leave future of mental health, substance use hotlines uncertain In a meeting about HHS layoffs, employees asked about the National Quit Line and Maternal Mental Health Hotline. Managers didn't know. By Isabella Cueto NIH Why a small journal's 'blueprint for NIH' may offer clues to the agency's future Author of 'A Blueprint for NIH Reform' has ties to new agency chief Jay Bhattacharya. Is it a roadmap or a revenge list from Covid critics? By Anil Oza STAT+ | A running list of senior FDA officials who have left the agency Turnover is routine in Washington. But under President Trump, there have been a flood of departures from the FDA. Keep track of who has exited. By Lizzy Lawrence and J. Emory Parker Inquiry by New York congressman reveals frustration over UnitedHealth practices in Hudson Valley U.S. Rep. Pat Ryan's survey reveals hundreds of complaints of billing problems, poor customer service, and an inability to get timely care By Casey Ross Adobe Opinion: The Johnson & Johnson cancer drug scandal that encapsulates corruption in health care EPO's history demonstrates just how unscrupulous one of America's most important companies and the nation's educated elite truly can be. By Gardiner Harris STAT+ | HHS deputy secretary pick O'Neill discloses history of work with vaccine developers President Trump's pick to be second-in-command at HHS has a history of working with vaccine companies and other health care firms. By Daniel Payne STAT+ | What FDA cuts could mean for the future of tobacco Experts say FDA cuts will create problems in tobacco regulation and enforcement, with potentially dire consequences for the fight against chronic disease. By Sarah Todd

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser